Lars Viktrup Selected Research

Low Back Pain (Lumbago)

4/2022	Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase III safety study.
1/2022	Exploring patient preference heterogeneity for pharmacological treatments for chronic pain: A latent class analysis.
1/2020	Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety.
10/2019	Nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: mechanism of action in the context of efficacy and safety.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lars Viktrup Research Topics

Disease

32	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2019 - 10/2008
31	Lower Urinary Tract Symptoms 01/2019 - 10/2008
18	Osteoarthritis 03/2022 - 01/2019
16	Pain (Aches) 01/2022 - 10/2018
16	Erectile Dysfunction 01/2019 - 10/2008
9	Stress Urinary Incontinence 02/2010 - 01/2004
6	Hip Osteoarthritis (Coxarthrosis) 03/2022 - 01/2019
5	Major Depressive Disorder (Major Depressive Disorders) 01/2007 - 01/2004
4	Low Back Pain (Lumbago) 04/2022 - 10/2019
4	Knee Osteoarthritis 01/2022 - 01/2020
3	Chronic Pain 01/2022 - 10/2019
3	Arthralgia (Joint Pain) 01/2021 - 01/2019
3	Urinary Incontinence 06/2008 - 01/2005
2	Neuralgia (Stump Neuralgia) 01/2007 - 11/2005
1	Radiculopathy (Radiculopathy, Cervical) 03/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 03/2022
1	Polyneuropathies (Polyneuropathy) 03/2022
1	Mononeuropathies (Mononeuritis Multiplex) 03/2022
1	Hypesthesia (Numbness) 01/2022
1	Paresthesia (Dysesthesia) 01/2022
1	Bradycardia 01/2022
1	Orthostatic Hypotension (Postural Hypotension) 01/2022
1	Nocturia 10/2014
1	Polyuria 10/2014
1	Hypertension (High Blood Pressure) 09/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2013
1	Back Pain (Backache) 11/2011
1	Headache (Headaches) 11/2011
1	Ischemia 03/2011
1	Hyperhidrosis 06/2008
1	Fatigue 06/2008
1	Constipation 06/2008
1	Lung Diseases (Lung Disease) 07/2007
1	Obesity 07/2007
1	Diabetes Mellitus 07/2007
1	Fibromyalgia (Fibrositis) 01/2007
1	Anxiety Disorders (Anxiety Disorder) 01/2007
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2004
1	Mania (Manias) 01/2004
1	Urinary Retention 01/2004

Drug/Important Bio-Agent (IBA)

32	Tadalafil (Cialis)FDA Link 01/2019 - 10/2008
17	tanezumabIBA 04/2022 - 10/2018
10	Duloxetine Hydrochloride (Cymbalta)FDA Link 02/2010 - 01/2004
8	Phosphodiesterase 5 InhibitorsIBA 10/2015 - 10/2008
7	Nerve Growth Factor (NGF)IBA 01/2022 - 10/2018
5	Prostaglandins AIBA 01/2022 - 01/2019
5	Analgesics (Analgesic Drugs)IBA 11/2021 - 01/2019
5	Tamsulosin (Flomax)FDA LinkGeneric 01/2019 - 09/2011
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2022 - 01/2020
4	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2005 - 01/2004
4	Serotonin (5 Hydroxytryptamine)IBA 11/2005 - 01/2004
3	Finasteride (Propecia)FDA LinkGeneric 06/2015 - 03/2014
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2004
2	Opioid Analgesics (Opioids)IBA 11/2021 - 01/2020
2	Acetaminophen (Paracetamol)FDA LinkGeneric 11/2021 - 01/2020
2	AntibodiesIBA 11/2021 - 10/2019
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 10/2015 - 09/2013
1	Celecoxib (Celebrex)FDA Link 04/2022
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 03/2011
1	Phosphotransferases (Kinase)IBA 03/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2011
1	Antidepressive Agents (Antidepressants)IBA 01/2004

Therapy/Procedure

8	Therapeutics 07/2021 - 02/2010
2	Drug Therapy (Chemotherapy) 07/2021 - 01/2004
2	Replacement Arthroplasty 01/2021 - 01/2019
1	Combined Modality Therapy 01/2020
1	Institutionalization (Institutionalized Persons) 01/2005